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Abstract  
There are only few case reports in the literature documenting outcome of pregnancy in patients with DM in contrast with those of other connective 
tissue diseases especially when dermatomyositis is revealed during pregnancy , most of the publications reported a poor prognosis for both the 
mother and the fetus , yet, in our case we confirmed the results of the rare recent cases that have tended to show a good outcome, after the 
treatment with glucocorticoid and immunosuppressant therapy. 
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Dermatomyositis (DM) is an idiopathic connective tissue disease 
characterized by specific cutaneous findings and inflammatory 
lesions in the muscle biopsy [1]. The onset of dermatomyositis 
during pregnancy is a rare event [2]. 17% of DM known before 
pregnancy will relapse during the pregnancy period and when the 
DM begins or relapses during pregnancy, the prognosis is pejorative 
with fetal death in 50% of cases, but successful therapy will permit 
a satisfactory result [3]. We report a rare case of DM revealed 




Patient and observation 
 
A 28-year-old woman in the third month of pregnancy, who 
presented with a pruritic rash of the face, hands, buttocks and the 
thighs that appeared at 4 weeks of gestation. She had not taken 
any medicine before the rash appeared. She did not complain of 
muscle pain, with a slight fatigue and there was no personal or 
family history of connective tissue disease. Examination revealed a 
pink liliace periocular erythro edema of the face (Figure 1), pruritic 
papules on the dorsal hands, elbows and a purplish erythema of the 
buttocks (Figure 2), the external surface of the thighs (Figure 3) 
and arms (Figure 4), neck and neckline (Figure 5), congestive 
erythema of the posterior nail fold with Periungual telangiectasia 
and hyperkeratosis of the cuticle were also observed , 
neuromuscular examination revealed a slight deficit of the pelvic 
girdle. Results of complete blood counts, blood biochemistry 
analysis, and urine analysis were within normal limits. Although 
antinuclear antibody titer (1:160) was positive, other auto 
antibodies were negative. A skin and muscle biopsy was compatible 
with DM with electric signs confirming the DM in the 
electromyogram. Based on these findings, this patient was 
diagnosed as DM revealed during pregnancy .Potent topical steroids 
with Hydroxychloroquine were prescribed, but the eruption did not 
improve with exacerbation of the erythroedema of the skin and the 
muscle weakness and the elevation of muscle enzymes, so we 
prescribed corticosteroid therapy for the patient with good evolution 
and she delivered a healthy newborn at term. The rash began to 
disappear progressively after delivery, so, the dose reduction of the 
corticosteroids was maintained gradually; also; both the mother and 






Dermatomyositis is a rare medical disease complicating pregnancy 
[4], various factors have been considered as triggers for 
development of DM during pregnancy; for example, exposure of the 
mother to fetal antigens, changes in maternal hormonal status, and 
the reactivation of certain viruses by pregnancy. Recently it has 
been proposed that microchimerism may contribute to the 
pathogenesis of autoimmune diseases [5-8]. There are only few 
case reports in the literature documenting outcome of pregnancy in 
patients with DM in contrast with those of other connective tissue 
diseases , yet , most of the publications reported a poor prognosis 
for both the mother and the fetus ; maternal death has been 
described and attached to complications of hypertension and the 
disease evolution [9]. In addition, prematurity may occur or even 
fetal death in 50% of cases [10-13] or the occurrence of Juvenile 
DM after post partum [14]. Some authors suggest that the outlook 
for the fetus is unfavorable when DM is first diagnosed during 
pregnancy [15], for example, in the study of Gutiearrez et al [16] of 
18 women with polymyositis/ dermatomyositis, there was 55% of 
increase in the rate of fetal loss and 50% of pregnancies ended 
prematurely and there was no correlation between disease activity 
and fetal loss. 
  
Other authors consider that fetal prognosis parallels the activity of 
maternal disease, which was also reported in the study of Silva et al 
[17] who published a more detailed series of pregnancy in 28 
women with dermatomyositis and polymyositis and concluded that 
the more active the myositis during pregnancy, the greater the 
chances of fetal loss. Generally, Optimal pregnancy success can be 
anticipated when pregnancy is undertaken with disease in 
remission. Some rare cases [18, 19] have tended to show a good 
outcome, after the treatment with oral corticosteroids. The use of 
steroids as first-line therapy is indicated for maternal disease 
exacerbation during pregnancy, as in the non-pregnant state. Other 
chemotherapeutic agents, such as intravenous immunoglobulins and 
antineoplastic agents can be used as second-line drugs to control 
disease activity and to maintain pregnancy. 
  
These cases and studies concerns mostly patients followed for DM 
and became pregnant, but there is only a few data concerning the 
management, the fetal and maternal prognosis in DM revealed 
during pregnancy. For example, in the largest series reported in the 
literature, there were only 2 patients among 98 who developed 
dermatomyositis during pregnancy with good control of the disease 
after glucocorticoid and immunosuppressant therapy [20]. In our 
case, we administered corticosteroids after the failure of steroid 
ointment and Hydroxychloroquine with good outcome, and the 





Our case documents the theory that, DM onset during pregnancy 
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Figure 1: DM showing pink liliaceperiocular erythro edema of the 
face  
Figure 2: DM showing erythema of the external face of the arms  
Figure 3: DM showing purplish erythema of the buttocks  
Figure 4: DM showing erythema of the external face of the thighs  
Figure 5: DM showing purplish erythema of the neck and neckline 
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Figure 1: DM showing pink liliaceperiocularerythro 
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Figure 3: DM showing erythema of 




Figure 4: DM showing erythema of 




Figure 5: DM showing purplish 
erythema of the neck and neckline 
 
